T Vigano, A Habib, A Hernandez, A Bonazzi, D Boraschi, M Lebret, E Cassina, J Maclouf, A Sala and G Folco
Institute of Pharmacological Sciences, School of Pharmacy, University of Milan, Italy.

The purpose of this study was to determine the mechanism of enhanced prostaglandin synthesis in cultured human bronchial smooth-muscle cells challenged with interleukin-1 beta (IL-1 beta). Cells were incubated with IL-1 beta (10 to 50 U/ml) for 0 to 24 h. Prostaglandin E2 (PGE2) production was evaluated through the conversion of exogenous (14C)- arachidonic acid and specific enzyme immunoassay of endogenous products. IL-1 beta enhanced PGE2 formation in a concentration- and time-dependent manner, reaching its peak at 6 to 8 h and fading at 18 to 24 h. Immunoblot analysis showed that the inducible cyclooxygenase enzyme (COX-2) was expressed only in IL-1 beta treated cells, whereas the constitutive isoform of cyclooxygenase (COX-1) remained unaltered. COX-2 expression and PGE2 formation were inhibited by dexamethasone (2 microM), cycloheximide (10 microM), and IL-1-receptor antagonist (IL-1 ra) (250 ng/ml), independently. PGE2 synthesis was significantly reduced by compound SC-58125, a specific COX-2 inhibitor. The close parallelism between the kinetics of COX-2 protein expression and PGE2 accumulation, as well as the constitutive nature of COX-1 isoform, indicate that IL-1 beta-driven PGE2 formation in human bronchial smooth- muscle cells is mediated by de novo expression of COX-2 enzyme.

This article has been cited by other articles:

				R. S. Lan, G. A. Stewart, R. G. Goldie, and P. J. Henry Altered expression and in vivo lung function of protease-activated receptors during influenza A virus infection in mice Am J Physiol Lung Cell Mol Physiol, February 1, 2004; 286(2): L388 - L398. [Abstract] [Full Text] [PDF]

				L. S. Chambers, J. L. Black, Q. Ge, S. M. Carlin, W. W. Au, M. Poniris, J. Thompson, P. R. Johnson, and J. K. Burgess PAR-2 activation, PGE2, and COX-2 in human asthmatic and nonasthmatic airway smooth muscle cells Am J Physiol Lung Cell Mol Physiol, September 1, 2003; 285(3): L619 - L627. [Abstract] [Full Text] [PDF]

				S. Page, A. J. Ammit, J. L. Black, and C. L. Armour Human mast cell and airway smooth muscle cell interactions: implications for asthma Am J Physiol Lung Cell Mol Physiol, December 1, 2001; 281(6): L1313 - L1323. [Abstract] [Full Text] [PDF]

				M. R. ACCOMAZZO, G. E. ROVATI, T. VIGANÒ, A. HERNANDEZ, A. BONAZZI, M. BOLLA, F. FUMAGALLI, S. VIAPPIANI, E. GALBIATI, S. RAVASI, et al. Leukotriene D4-Induced Activation of Smooth-Muscle Cells From Human Bronchi Is Partly Ca2+-Independent Am. J. Respir. Crit. Care Med., January 1, 2001; 163(1): 266 - 272. [Abstract] [Full Text]

				P. R. A. JOHNSON, J. L. BLACK, S. CARLIN, Q. GE, and P. ANNE UNDERWOOD The Production of Extracellular Matrix Proteins by Human Passively Sensitized Airway Smooth-Muscle Cells in Culture . The Effect of Beclomethasone Am. J. Respir. Crit. Care Med., December 1, 2000; 162(6): 2145 - 2151. [Abstract] [Full Text]

				A. BONAZZI, M. BOLLA, C. BUCCELLATI, A. HERNANDEZ, S. ZARINI, T. VIGANÒ, F. FUMAGALLI, S. VIAPPIANI, S. RAVASI, P. ZANNINI, et al. Effect of Endogenous and Exogenous Prostaglandin E2 on Interleukin-1{beta}-Induced Cyclooxygenase-2 Expression in Human Airway Smooth-Muscle Cells Am. J. Respir. Crit. Care Med., December 1, 2000; 162(6): 2272 - 2277. [Abstract] [Full Text]

				L. Ermert, M. Ermert, M. Merkle, M. Goppelt-Struebe, H.-R. Duncker, F. Grimminger, and W. Seeger Rat Pulmonary Cyclooxygenase-2 Expression in Response to Endotoxin Challenge : Differential Regulation in the Various Types of Cells in theLung Am. J. Pathol., April 1, 2000; 156(4): 1275 - 1287. [Abstract] [Full Text] [PDF]

				J. D. Laporte, P. E. Moore, J. H. Abraham, G. N. Maksym, B. Fabry, R. A. Panettieri Jr., and S. A. Shore Role of ERK MAP kinases in responses of cultured human airway smooth muscle cells to IL-1beta Am J Physiol Lung Cell Mol Physiol, November 1, 1999; 277(5): L943 - L951. [Abstract] [Full Text] [PDF]

				Y. Amrani, A. L. Lazaar, and R. A. Panettieri Jr. Up-Regulation of ICAM-1 by Cytokines in Human Tracheal Smooth Muscle Cells Involves an NF-{kappa}B-Dependent Signaling Pathway That Is Only Partially Sensitive to Dexamethasone J. Immunol., August 15, 1999; 163(4): 2128 - 2134. [Abstract] [Full Text] [PDF]

				S. J. HIRST and T. H. LEE Airway Smooth Muscle as a Target of Glucocorticoid Action in the Treatment of Asthma Am. J. Respir. Crit. Care Med., November 1, 1998; 158(2007): S201 - S206. [Abstract] [Full Text] [PDF]

				L. Ermert, M. Ermert, A. Althoff, M. Merkle, F. Grimminger, and W. Seeger Vasoregulatory Prostanoid Generation Proceeds Via Cyclooxygenase-2 in Noninflamed Rat Lungs J. Pharmacol. Exp. Ther., September 1, 1998; 286(3): 1309 - 1314. [Abstract] [Full Text]

				J. D. Laporte, P. E. Moore, R. A. Panettieri, W. Moeller, J. Heyder, and S. A. Shore Prostanoids mediate IL-1beta -induced beta -adrenergic hyporesponsiveness in human airway smooth muscle cells Am J Physiol Lung Cell Mol Physiol, September 1, 1998; 275(3): L491 - L501. [Abstract] [Full Text] [PDF]

				L. Pang, E. Holland, and A. J. Knox Impaired cAMP production in human airway smooth muscle cells by bradykinin: role of cyclooxygenase products Am J Physiol Lung Cell Mol Physiol, August 1, 1998; 275(2): L322 - L329. [Abstract] [Full Text] [PDF]